Similar to IDO, tryptophan 2,3-dioxygenase (TDO) is expressed by cancer cells in various human tumors (Pilotte et al., 2012) and its activity, presumably through tryptophan depletion or kynurenine (Box 1) production, induces immune dysfunction (Schmidt et al., 2009). The gene discussed is IDO1; the disease is cancer.